NASDAQ:AKBA

Akebia Therapeutics SEC Filings & 10K Form

$3.06
-0.10 (-3.16 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.06
Now: $3.06
$3.17
50-Day Range
$3.06
MA: $3.51
$4.44
52-Week Range
$2.09
Now: $3.06
$13.71
Volume2.99 million shs
Average Volume6.43 million shs
Market Capitalization$469.72 million
P/E RatioN/A
Dividend YieldN/A
Beta2.11

SEC Filings

Akebia Therapeutics (NASDAQ:AKBA) SEC Filings

DateFilerForm TypeView
04/01/2021
7:35 PM
Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
7:34 PM
Akebia Therapeutics (Issuer)
Spellman David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
7:33 PM
Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
7:33 PM
Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
7:32 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
7:31 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
8:07 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2021
6:19 PM
Akebia Therapeutics (Issuer)
Spellman David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
6:18 PM
Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
6:18 PM
Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
6:17 PM
Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
6:17 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
6:16 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
4:21 PM
Akebia Therapeutics (Filer)
Form S-3ASR
02/25/2021
7:04 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2021
7:17 AM
Akebia Therapeutics (Issuer)
ZUMWALT LEANNE M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
7:15 AM
Akebia Therapeutics (Issuer)
ZUMWALT LEANNE M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/18/2021
7:03 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
5:42 AM
Akebia Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13G/A
02/11/2021
11:43 AM
Akebia Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/03/2021
12:33 PM
Akebia Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/28/2021
4:03 PM
Akebia Therapeutics (Issuer)
Cotreau Violetta (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/28/2021
3:29 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2021
3:11 PM
Akebia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/12/2021
6:06 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2020
7:22 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2020
3:17 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2020
8:02 AM
Akebia Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/05/2020
7:15 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
1:44 PM
Akebia Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/09/2020
2:44 PM
Akebia Therapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
Form SC 13G/A
09/25/2020
12:00 PM
Akebia Therapeutics (Filer)
Form CT ORDER
09/25/2020
7:16 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2020
4:00 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2020
3:55 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
3:02 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2020
11:54 AM
Akebia Therapeutics (Filer)
Form CT ORDER
06/18/2020
3:16 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2020
11:02 AM
Akebia Therapeutics (Filer)
Form CT ORDER
05/21/2020
3:16 PM
Akebia Therapeutics (Filer)
Form DEFA14A
05/12/2020
3:18 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
3:02 PM
Akebia Therapeutics (Filer)
Form 424B5
05/05/2020
3:12 PM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2020
7:22 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2020
7:58 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
8:08 PM
Akebia Therapeutics (Filer)
Form PRER14A
04/10/2020
3:06 PM
Akebia Therapeutics (Filer)
Form PRE 14A
04/09/2020
3:11 PM
Akebia Therapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
Form SC 13G/A
04/08/2020
3:44 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2020
7:31 AM
Akebia Therapeutics (Issuer)
Wolf Myles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
7:30 AM
Akebia Therapeutics (Issuer)
Wolf Myles (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/07/2020
7:12 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2020
3:58 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2020
3:56 PM
Akebia Therapeutics (Filer)
Form 424B5
03/10/2020
7:08 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
6:29 PM
Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
6:28 PM
Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
6:27 PM
Akebia Therapeutics (Issuer)
Amello Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
6:26 PM
Akebia Therapeutics (Issuer)
Tubridy Karen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
6:26 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
6:25 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
6:25 PM
Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
6:00 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2020
12:05 PM
Akebia Therapeutics (Filer)
Form CT ORDER
11/22/2019
5:20 AM
Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:20 AM
Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:19 AM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
5:32 AM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
5:31 AM
ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
4:31 PM
Akebia Therapeutics (Filer)
Form 424B5
11/12/2019
4:20 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:31 PM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
7:59 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
11:52 AM
Akebia Therapeutics (Filer)
Form CT ORDER
09/11/2019
3:15 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
3:03 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:48 PM
Akebia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2019
7:22 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
3:04 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2019
3:10 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
Morrison Jodie Pope (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
Enyedy Mark J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:03 PM
Akebia Therapeutics (Issuer)
Canute Scott A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:03 PM
ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
6:00 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:07 PM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:02 PM
Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2019
7:18 AM
Akebia Therapeutics (Filer)
Form DEFA14A
05/09/2019
7:16 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:05 PM
Akebia Therapeutics (Filer)
Form DEF 14A
04/18/2019
6:50 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
3:01 PM
Akebia Therapeutics (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:01 PM
Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:00 PM
Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.